ASCO 2023 – AstraZeneca – Positive Results from ADAURA Phase III Trial
Roy Herbst, MD, PhD, from the Yale School of Medicine and primary investigatory of the ADAURA Phase III trial discusses the positive results that show T...
5345 articles
Roy Herbst, MD, PhD, from the Yale School of Medicine and primary investigatory of the ADAURA Phase III trial discusses the positive results that show T...
Mark Stadler, CEO of AccessHope discusses cancer care and why access to the best cancer facilities is out of reach for the majority of Americans, partic...
Melinda Greenfield discusses plaque psoriasis and how moderate-to-severe plaque psoriasis patients can make the most of warm weather.
Ahsan Arozullah, MD, MPH, Senior Vice President, Head of Oncology Development at Astellas discusses the company's presence at the 2023 American Soci...
Sean Gilligan, Chief Operating Officer at AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arter...
Curtis Barnett, President and CEO of Arkansas Blue Cross and Blue Shield, discusses his belief in the importance of addressing behavioral healthcare nee...
Joe Ferra, Interim CEO and CFO of Elevation Oncology discusses the company's development of an antibody-drug conjugate (ADC) that targets Claudin18.2, a...
Gloria Caulfield, Vice President of Strategic Alliances for Tavistock and Executive Director of the Lake Nona Institute discusses the Lake Nona communit...
Steve Kent, Chief Product Officer at Know Labs, Inc., an emerging developer of non-invasive medical diagnostic technology, discusses the completion of i...
Andrea Furlan, MD, PhD, Associate Professor in the Department of Medicine at the University of Toronto and a Staff Physician and Senior Scientist at the...